NCT01534585: Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma |
|
|
| Completed | 1/2 | 48 | RoW | Icotinib, Conmana, intensity-modulated radiotherapy, IMRT, Paclitaxel and Cisplatin, Quality of life, QoL, Epidermal growth factor receptor status, EGFR | Taizhou Hospital | Nasopharyngeal Carcinoma | 02/13 | 02/15 | | |
